In the year 2000 the U.S.
Food and Drug Administration (FDA) approved the drug mifepristone (also known
as RU-486 or Mifeprex) as part of a regimen for chemically induced abortions.
But on April 7, 2023—late on Good Friday—a federal judge in Texas issued a
preliminary injunction that suspended the FDA’s approval of mifepristone,
pending a trial on the merits of the case. The preliminary injunction was
partially reversed on appeal, but the judge’s opinion in Alliance for
Hippocratic Medicine v. FDA casts a spotlight on the damage that
mifepristone has caused to women and their preborn children. Host Michael
Pauley is joined by Adam Schwend of Susan B. Anthony Pro-Life America to
discuss the implications of the Alliance for Hippocratic Medicine case,
regarded by many legal experts as the most important abortion-related
litigation since the Dobbs decision.